Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma

Fig. 1

Comparison of serum squamous cell carcinoma (SCC) antigen levels between different treatments. a The SCC antigen levels of patients in the NACT and conventional groups; b The SCC antigen levels of patients in the NACT group before chemotherapy, after the first chemotherapy and before surgery; c and d The SCC antigen levels of patients in the chemotherapy-sensitive and chemotherapy-insensitive groups before and after the first chemotherapy

Back to article page